Published in J Cereb Blood Flow Metab on January 01, 2004
Deep brain stimulation. Annu Rev Neurosci (2006) 2.65
Network modulation in the treatment of Parkinson's disease. Brain (2006) 2.52
Common and unique responses to dopamine agonist therapy and deep brain stimulation in Parkinson's disease: an H(2)(15)O PET study. Brain Stimul (2011) 1.98
Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage (2006) 1.84
The cerebellum and basal ganglia are interconnected. Neuropsychol Rev (2010) 1.70
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry (2005) 1.69
Cerebellar networks with the cerebral cortex and basal ganglia. Trends Cogn Sci (2013) 1.68
Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction. Eur J Nucl Med Mol Imaging (2007) 1.49
Neuroimaging and therapeutics in movement disorders. NeuroRx (2005) 1.17
Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease. Mol Imaging Biol (2007) 1.03
Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia (2008) 1.03
Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients. Stereotact Funct Neurosurg (2008) 0.97
Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study. Eur J Nucl Med Mol Imaging (2010) 0.94
High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat. Exp Brain Res (2007) 0.94
Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. J Neurol (2009) 0.93
Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study. Brain (2008) 0.93
FDG-PET findings in patients with galactosaemia. J Inherit Metab Dis (2008) 0.92
Mechanisms of unilateral STN-DBS in patients with Parkinson's disease : a PET study. J Neurol (2008) 0.91
Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease. Neurosci Biobehav Rev (2013) 0.90
Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J Neural Transm (Vienna) (2005) 0.89
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. Eur J Nucl Med Mol Imaging (2007) 0.89
Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci (2012) 0.87
The serendipity case of the pedunculopontine nucleus low-frequency brain stimulation: chasing a gait response, finding sleep, and cognition improvement. Front Neurol (2013) 0.86
Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flow. J Cereb Blood Flow Metab (2011) 0.85
Modulation of human time processing by subthalamic deep brain stimulation. PLoS One (2011) 0.84
Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease. PLoS One (2010) 0.84
Timing of deep brain stimulation in Parkinson disease: a need for reappraisal? Ann Neurol (2013) 0.84
SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation. J Neurol (2009) 0.84
Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method. Surg Radiol Anat (2005) 0.83
Reduced GABA Content in the Motor Thalamus during Effective Deep Brain Stimulation of the Subthalamic Nucleus. Front Syst Neurosci (2011) 0.83
Neural circuit modulation during deep brain stimulation at the subthalamic nucleus for Parkinson's disease: what have we learned from neuroimaging studies? Brain Connect (2013) 0.82
The Subthalamic Nucleus, Limbic Function, and Impulse Control. Neuropsychol Rev (2015) 0.81
Deep brain stimulation in Parkinson's disease. Transl Neurodegener (2013) 0.81
Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. Mov Disord (2009) 0.79
A network analysis of ¹⁵O-H₂O PET reveals deep brain stimulation effects on brain network of Parkinson's disease. Yonsei Med J (2015) 0.79
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus? J Neural Transm (Vienna) (2010) 0.79
Brain energization in response to deep brain stimulation of subthalamic nuclei in Parkinson's disease. J Cereb Blood Flow Metab (2011) 0.79
Amplitude of low-frequency oscillations in Parkinson's disease: a 2-year longitudinal resting-state functional magnetic resonance imaging study. Chin Med J (Engl) (2015) 0.79
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. Cell Death Dis (2011) 0.78
Tractography patterns of subthalamic nucleus deep brain stimulation. Brain (2016) 0.78
Human gene therapy and imaging in neurological diseases. Eur J Nucl Med Mol Imaging (2005) 0.77
PET measurement of changes in D2/D3 dopamine receptor binding in a nonhuman primate during chronic deep brain stimulation of the bed nucleus of the stria terminalis. J Neurosci Methods (2008) 0.77
Deep Brain Stimulation of the Subthalamic Nucleus Improves Lexical Switching in Parkinsons Disease Patients. PLoS One (2016) 0.76
Role of functional imaging in the development and refinement of invasive neuromodulation for psychiatric disorders. World J Radiol (2014) 0.76
Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease. Neurosci Bull (2014) 0.75
The Safety of Using Body-Transmit MRI in Patients with Implanted Deep Brain Stimulation Devices. PLoS One (2015) 0.75
Network effects of deep brain stimulation. J Neurophysiol (2015) 0.75
Molecular imaging of movement disorders. World J Radiol (2016) 0.75
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov (2010) 4.55
Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology (2007) 3.81
Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke (2003) 3.53
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol (2008) 2.83
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol (2005) 2.65
Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology (2008) 2.65
Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int (2010) 2.60
Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg (2009) 2.57
Performance evaluation of the microPET R4 PET scanner for rodents. Eur J Nucl Med Mol Imaging (2003) 2.47
Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry (2010) 2.46
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) (2011) 2.34
Extracellular concentrations of non-transmitter amino acids in peri-infarct tissue of patients predict malignant middle cerebral artery infarction. Stroke (2003) 2.15
The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat (2003) 2.08
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol (2005) 1.82
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Good vibrations: cross-frequency coupling in the human nucleus accumbens during reward processing. J Cogn Neurosci (2009) 1.69
Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med (2011) 1.67
Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke (2005) 1.59
Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? J Neurol Neurosurg Psychiatry (2007) 1.56
PET/MRI for neurologic applications. J Nucl Med (2012) 1.55
Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus. Exp Neurol (2012) 1.55
Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia. World Neurosurg (2012) 1.55
Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg (2002) 1.51
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol (2003) 1.50
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke (2014) 1.49
Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res (2004) 1.48
Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci (2006) 1.46
Predicting acute affective symptoms after deep brain stimulation surgery in Parkinson's disease. Stereotact Funct Neurosurg (2010) 1.46
18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med (2005) 1.44
Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun (2011) 1.44
Decision-making impairments in patients with pathological gambling. Psychiatry Res (2005) 1.43
Clinical outcome of subthalamic stimulation in Parkinson's disease is improved by intraoperative multiple trajectories microelectrode recording. J Neurol Surg A Cent Eur Neurosurg (2012) 1.42
The causal relationship between subcortical local field potential oscillations and Parkinsonian resting tremor. J Neural Eng (2010) 1.41
Fast and robust registration of PET and MR images of human brain. Neuroimage (2004) 1.41
Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease. Mov Disord (2004) 1.40
Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke (2010) 1.39
Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology (2012) 1.38
Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clin Cancer Res (2008) 1.36
Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome. J Neurol (2007) 1.33
Heterogeneity in the penumbra. J Cereb Blood Flow Metab (2011) 1.33
Decision-making deficits of korsakoff patients in a new gambling task with explicit rules: associations with executive functions. Neuropsychology (2005) 1.31
Introducing MASC: a movie for the assessment of social cognition. J Autism Dev Disord (2006) 1.31
Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. J Cereb Blood Flow Metab (2005) 1.29
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med (2011) 1.28
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord (2006) 1.25
Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage (2003) 1.23
Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Hum Brain Mapp (2006) 1.21
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 1.21
Nuclei accumbens phase synchrony predicts decision-making reversals following negative feedback. J Neurosci (2009) 1.21
Decision-making impairments in patients with Parkinson's disease. Behav Neurol (2004) 1.20
Intracranial EEG correlates of expectancy and memory formation in the human hippocampus and nucleus accumbens. Neuron (2010) 1.20
Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol (2004) 1.17
Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol (2006) 1.16
Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch Neurol (2005) 1.15
Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J Nucl Med (2002) 1.15
Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol (2009) 1.15
Imaging in neurooncology. NeuroRx (2005) 1.14
Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord (2003) 1.14
Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol (2004) 1.14
Visualization of abscess formation in a murine thigh infection model of Staphylococcus aureus by 19F-magnetic resonance imaging (MRI). PLoS One (2011) 1.12
Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study. Neuropsychologia (2009) 1.12
Nonpharmacological enhancement of cognitive function in Parkinson's disease: a systematic review. Mov Disord (2013) 1.10
From the left to the right: How the brain compensates progressive loss of language function. Brain Lang (2006) 1.09
Nucleus Accumbens is Involved in Human Action Monitoring: Evidence from Invasive Electrophysiological Recordings. Front Hum Neurosci (2008) 1.09
Hemodynamic and metabolic effects of decompressive hemicraniectomy in normal brain. An experimental PET-study in cats. Brain Res (2003) 1.08
Partial occlusion of the descending aorta increases cerebral blood flow in a nonstroke porcine model. Cerebrovasc Dis (2009) 1.08
Brain receptor imaging. J Nucl Med (2006) 1.06
Perfusion computer tomography helps to differentiate seizure and stroke in acute setting. Clin Neurol Neurosurg (2011) 1.06
Direct demonstration of transcallosal disinhibition in language networks. J Cereb Blood Flow Metab (2006) 1.06
Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging (2003) 1.06